{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:57:09Z","timestamp":1773028629977,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T00:00:00Z","timestamp":1176336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2007,9,1]]},"DOI":"10.1007\/s10620-006-9729-5","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T17:51:54Z","timestamp":1176918714000},"page":"2557-2563","source":"Crossref","is-referenced-by-count":25,"title":["Preventing Relapse of Major Depression During Interferon-\u03b1 Therapy for Hepatitis C\u2014A Pilot Study"],"prefix":"10.1007","volume":"52","author":[{"given":"Ondria C.","family":"Gleason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Fucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle A.","family":"Philipsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,12]]},"reference":[{"key":"9729_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15622970310029904","volume":"4","author":"B Gohier","year":"2003","unstructured":"Gohier B, Goeb JL, Rannou-Dubas K, Fouchard I, Cal\u00e8s P, Garr\u00e9 JB (2003) Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. World J Biol Psychiatry 4:115\u2013118","journal-title":"World J Biol Psychiatry"},{"key":"9729_CR2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/gast.2002.34750","volume":"123","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB, Kunik M, Richardson P, Rabeneck L (2002) Psychiatic disorders among veterans with hepatitis C infection. Gastroenterology 123:476\u2013482","journal-title":"Gastroenterology"},{"issue":"23","key":"9729_CR3","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.292.23.2839","volume":"292","author":"F Carrat","year":"2004","unstructured":"Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-C\u00e9ron D, Degott C, Cacoub P, Perronne C, ANRS HCO2 RIBAVIC Study Team (2004) Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292(23):2839\u20132848","journal-title":"JAMA"},{"issue":"13","key":"9729_CR4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gon\u00e7ales FL, H\u00e4ussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347(13):975\u2013982","journal-title":"N Engl J Med"},{"key":"9729_CR5","unstructured":"Complete Product Information and Pegasys Medication Guide (2006) Available at: http:\/www.rocheusa.com\/products\/pegasys\/ pi.pdf; retrieved July 12, 2006"},{"key":"9729_CR6","unstructured":"Peg Intron (2006) Product Information Page. Rev. 02\/05. Available at: http:\/\/www.spfiles.com\/pipeg-intron.pdf; retrieved August 17, 2006"},{"key":"9729_CR7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.mp.4001119","volume":"7","author":"P Hauser","year":"2002","unstructured":"Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J, Gulati M, Thornton AJ, Schultz RL, Valentine AD, Meyers CA, Howell CD (2002) A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 7:942\u2013947","journal-title":"Mol Psychiatry"},{"key":"9729_CR8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0033-3182(99)71190-4","volume":"40","author":"OC Gleason","year":"1999","unstructured":"Gleason OC, Yates WR (1999) Five cases of interferon-alfa-induced depression treated with antidepressant therapy. Psychosomatics 40:510\u2013512","journal-title":"Psychosomatics"},{"key":"9729_CR9","first-page":"760","volume":"88","author":"JL Levenson","year":"1993","unstructured":"Levenson JL, Fallon HJ (1993) Fluoxetine treatment of depression caused by interferon-alfa. Am J Gastroenterol 88:760\u2013761","journal-title":"Am J Gastroenterol"},{"key":"9729_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5694\/j.1326-5377.2000.tb125687.x","volume":"173","author":"TM Schramm","year":"2000","unstructured":"Schramm TM, Lawford BR, Macdonald GA, Cooksley WG (2000) Sertraline treatment of interferon-alfa-induced depressive disorder. Med J Aust 173:359\u2013361","journal-title":"Med J Aust"},{"key":"9729_CR11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1365-2036.2002.01265.x","volume":"16","author":"MR Kraus","year":"2002","unstructured":"Kraus MR, Sch\u00e4fer A, Faller H, Csef H, Scheurlen M (2002) Paroxetine for the treatment of interferon-alfa-induced depression in chronic hepatitis C. Aliment Pharmacol Ther 16:1091\u20131099","journal-title":"Aliment Pharmacol Ther"},{"key":"9729_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0033-3182(94)71769-2","volume":"35","author":"LS Goldman","year":"1994","unstructured":"Goldman LS (1994) Successful treatment of interferon alfa-induced mood disorder with nortiptyline [letter]. Psychosomatics 35:412\u2013413","journal-title":"Psychosomatics"},{"key":"9729_CR13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4088\/JCP.v63n0304","volume":"36","author":"OC Gleason","year":"2002","unstructured":"Gleason OC, Yates WR, Isbell MD, Philipsen MA (2002) An open-label trial of citalopram for major depression in patients with hepatitis C. J Clin Psychiatry 36:194\u2013198","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"9729_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4088\/PCC.v07n0503","volume":"7","author":"OC Gleason","year":"2005","unstructured":"Gleason OC, Yates WR, Philipsen MA (2005) Major depressive disorder in hepatitis C: an open-label trial of escitalopram. Prim Care Compan J Clin Psychiatry 7(5):225\u2013230","journal-title":"Prim Care Compan J Clin Psychiatry"},{"key":"9729_CR15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1176\/appi.psy.44.6.524","volume":"44","author":"JM Loftis","year":"2003","unstructured":"Loftis JM, Hauser P (2003) Safety of the treatment of interferon-alpha-induced depression [letter]. Psychosomatics 44:524\u2013526","journal-title":"Psychosomatics"},{"key":"9729_CR16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0002-9394(01)00836-4","volume":"131","author":"C Hejny","year":"2001","unstructured":"Hejny C, Sternburg P, Lawson DH, Greiner K, Aaberg Jr TM (2001) Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Opthalmol 131:782\u2013787","journal-title":"Am J Opthalmol"},{"key":"9729_CR17","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1176\/appi.ajp.162.7.1386","volume":"162","author":"T Ozcanli","year":"2005","unstructured":"Ozcanli T, Unsalver B, Ozdemir S, Ozmen M (2005) Sertraline- and mirtazapine-induced severe neutropenia [letter]. Am J Psychiatry 162:1386","journal-title":"Am J Psychiatry"},{"key":"9729_CR18","first-page":"1187","volume":"169","author":"S Choi","year":"2003","unstructured":"Choi S (2003) Nefazadone (Serzone) withdrawn because of hepatotoxicity. CMAJ 169:1187","journal-title":"CMAJ"},{"issue":"6","key":"9729_CR19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2005.01.020","volume":"42","author":"M Schaefer","year":"2005","unstructured":"Schaefer M, Schwaiger M, Garkisch AS, Pich M, Hinzpeter A, Uebelhack R, Heinz A, van Boemmel F, Berg T (2005) Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. J Hepatol 42(6):793\u2013798","journal-title":"J Hepatol"},{"key":"9729_CR20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/jhep.2000.7880","volume":"31","author":"D Zdilar","year":"2000","unstructured":"Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM (2000) Hepatitis C, interferon alfa, and depression. Hepatology 31:1207\u20131211","journal-title":"Hepatology"},{"issue":"Suppl 20","key":"9729_CR21","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Harnett-Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. J. Clin Psychiatry 59(Suppl 20):22\u201333","journal-title":"J. Clin Psychiatry"},{"key":"9729_CR22","unstructured":"Hamilton M (1976) Hamilton Depression Scale. In: ECDEU assessment manual for psychopharmacology. Rev. ed. Guy W (ed). U.S. Department of Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health, pp 179\u2013192"},{"key":"9729_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"9729_CR24","volume-title":"Screening for brain impairment: a manual for mental health practice","author":"R Berg","year":"1987","unstructured":"Berg R, Franzen M, Wedding D (1987) Screening for brain impairment: a manual for mental health practice. Springer, New York"},{"key":"9729_CR25","first-page":"81","volume-title":"Symptom Checklist-90-Revised (SCL-90-R) In: Task force for the handbook of psychiatric measures. Handbook of psychiatric measures","author":"LR Derogatis","year":"2000","unstructured":"Derogatis LR (2000) Symptom Checklist-90-Revised (SCL-90-R) In: Task force for the handbook of psychiatric measures. Handbook of psychiatric measures. American Psychiatric Association, Washington, DC, pp 81\u201384"},{"key":"9729_CR26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"9729_CR27","unstructured":"National Institute of Mental Health (1970) CGI: clinical global impressions. In: Manual for the ECDEU assessment battery, 2. Rev ed. Guy W, Bonato RR (eds). Chevy Chase, MD: National Institute of Mental Health, pp 12-1\u201312-6"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9729-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-006-9729-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9729-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T12:37:06Z","timestamp":1587472626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-006-9729-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,12]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,1]]}},"alternative-id":["9729"],"URL":"https:\/\/doi.org\/10.1007\/s10620-006-9729-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,12]]}}}